3:28 PM
 | 
Aug 09, 2018
 |  BC Extra  |  Company News

Management tracks: Grail, Celyad, Hua

Cancer detection company Grail Inc. (Menlo Park, Calif.) appointed Hal Barron and Hans Bishop to its board. Barron is CSO and president of R&D at GlaxoSmithKline plc (NYSE:GSK; LSE:GSK), and Bishop was president and CEO at Juno Therapeutics Inc., which Celgene Corp. (NASDAQ:CELG) acquired.

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >